Genprex’s CEO Appears on the Big Biz Show for a Second Time

Genprex’s Chairman and Chief Executive Officer, Rodney Varner, participates in a live interview with the “Big Biz Show” for a second time, providing details on its lead drug candidate for NSCLC, its diabetes gene therapy and what lies ahead in the next 18 months in the midst of COVID-19.